Neurophysiological markers of disease severity and cognitive dysfunction in major depressive disorder: a TMS-EEG study
-
Deyang Li [1] ; Xingxing Li [1] ; Jiaxin Li [1] ; Junyao Liu [1] ; Ruichenxi Luo [1] ; Yanli Li [1] ; Dongmei Wang [1] ; Dongsheng Zhou [2] ; Xiang-Yang Zhang [1]
-
[1] Chinese Academy of Sciences
Chinese Academy of Sciences
China
-
[2] Ningbo University
Ningbo University
China
-
- Localización: International journal of clinical and health psychology, ISSN 1697-2600, Vol. 24, Nº. 3, 2024, págs. 211-220
- Idioma: inglés
- Enlaces
-
Resumen
Background Transcranial magnetic stimulation-electroencephalography (TMS-EEG) is a powerful technique to study the neuropathology and biomarkers of major depressive disorder (MDD). This study investigated cortical activity and its relationship with clinical symptoms and cognitive dysfunction in MDD patients by indexing TMS-EEG biomarkers in the dorsolateral prefrontal cortex (DLPFC).
Methods 133 patients with MDD and 76 healthy individuals participated in this study. Single-pulse TMS was performed on the left DLPFC to obtain TMS-evoked potential (TEP) indices. TMS-EEG waveforms and components were determined by global mean field amplitude. We used the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to measure participants’ cognitive function.
Results Patients with MDD had a lower excitatory P180 index compared to healthy controls, and P180 amplitude was negatively correlated with the severity of depressive and anxiety symptoms in patients with MDD. In the MDD group, P30 amplitude was negatively associated with RBANS Visuospatial/ Constructional index and total score.
Conclusions TMS-EEG findings suggest that abnormal cortical excitation and inhibition induced by TMS on the DLPFC are associated with the severity of clinical symptoms and cognitive dysfunction in patients with MDD. P180 and P30 have the potential to serve as neurophysiological biomarkers of clinical symptoms and cognitive dysfunction in MDD patients, respectively.
